These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy. Lam JS; Shvarts O; Leppert JT; Figlin RA; Belldegrun AS J Urol; 2005 Jun; 173(6):1853-62. PubMed ID: 15879764 [TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant and adjuvant strategies in renal cell carcinoma: more questions than answers. Homicsko K; Berthold DR Anticancer Drugs; 2011 Jan; 22 Suppl 1():S4-8. PubMed ID: 21173604 [TBL] [Abstract][Full Text] [Related]
5. Can vaccination or tyrosine kinase inhibitor therapy play a role in the adjuvant treatment of renal cell carcinoma? Brookman-May S; May M; Gilfrich C; Wieland WF; Burger M Expert Rev Anticancer Ther; 2010 Jun; 10(6):813-23. PubMed ID: 20553207 [TBL] [Abstract][Full Text] [Related]
6. Integration of surgery and systemic therapy for renal cell carcinoma. Kenney PA; Wood CG Urol Clin North Am; 2012 May; 39(2):211-31, vii. PubMed ID: 22487764 [TBL] [Abstract][Full Text] [Related]
7. EORTC-GU group expert opinion on metastatic renal cell cancer. de Reijke TM; Bellmunt J; van Poppel H; Marreaud S; Aapro M Eur J Cancer; 2009 Mar; 45(5):765-73. PubMed ID: 19157861 [TBL] [Abstract][Full Text] [Related]
8. A survey of therapy for advanced renal cell carcinoma. Basso M; Cassano A; Barone C Urol Oncol; 2010; 28(2):121-33. PubMed ID: 19576800 [TBL] [Abstract][Full Text] [Related]
9. Novel immunotherapeutic strategies in development for renal cell carcinoma. Inman BA; Harrison MR; George DJ Eur Urol; 2013 May; 63(5):881-9. PubMed ID: 23084331 [TBL] [Abstract][Full Text] [Related]
10. The role of adjuvant therapy in non-metastatic RCC. Bleumer I; de Mulder PH; Mulders PF Can J Urol; 2006 Apr; 13 Suppl 2():57-62. PubMed ID: 16672131 [TBL] [Abstract][Full Text] [Related]
11. Treatment of metastatic renal cell carcinoma. Reeves DJ; Liu CY Cancer Chemother Pharmacol; 2009 Jun; 64(1):11-25. PubMed ID: 19343348 [TBL] [Abstract][Full Text] [Related]
12. Multimodal approaches in the management of locally advanced and metastatic renal cell carcinoma: combining surgery and systemic therapies to improve patient outcome. Wood CG Clin Cancer Res; 2007 Jan; 13(2 Pt 2):697s-702s. PubMed ID: 17255296 [TBL] [Abstract][Full Text] [Related]
13. Clinical outcome of combined immunotherapy with interferon-alpha and low-dose interleukine-2 for Japanese patients with metastatic renal cell carcinoma. Miyake H; Kurahashi T; Takenaka A; Inoue TA; Fujisawa M Urol Oncol; 2009; 27(6):598-603. PubMed ID: 18818106 [TBL] [Abstract][Full Text] [Related]
14. Renal cell carcinoma: current status and future prospects. Drucker BJ Cancer Treat Rev; 2005 Nov; 31(7):536-45. PubMed ID: 16236454 [TBL] [Abstract][Full Text] [Related]
15. [Treatment of renal cell carcinoma with interferons]. Oya M Nihon Rinsho; 2006 Jul; 64(7):1281-5. PubMed ID: 16838645 [TBL] [Abstract][Full Text] [Related]
16. Recent advances in the treatment of advanced renal cell carcinoma: towards multidisciplinary personalized care. Bex A; Gore M; Mulders P; Sternberg CN BJU Int; 2012 Nov; 110(9):1289-300. PubMed ID: 22624610 [TBL] [Abstract][Full Text] [Related]
17. Combination systemic therapy for advanced renal cell carcinoma. Miller RE; Larkin JM Oncologist; 2009 Dec; 14(12):1218-24. PubMed ID: 19939892 [TBL] [Abstract][Full Text] [Related]
18. Vaccine therapy in patients with renal cell carcinoma. Van Poppel H; Joniau S; Van Gool SW Eur Urol; 2009 Jun; 55(6):1333-42. PubMed ID: 19201522 [TBL] [Abstract][Full Text] [Related]
19. Everolimus in the treatment of renal cell carcinoma and neuroendocrine tumors. Chan HY; Grossman AB; Bukowski RM Adv Ther; 2010 Aug; 27(8):495-511. PubMed ID: 20623346 [TBL] [Abstract][Full Text] [Related]